Vaccine Development Related News
Enhancing treatment efficacy and antigen delivery with Accum
Defence Therapeutics outlines the potential of their innovative AccumTM technology to improve intracellular antigen delivery and ultimately enhance treatments for cancer and infectious diseases.
Defence...
Scientists discover a novel method to extend the shelf life of vaccines
New research illuminates the necessity of extending the shelf life of vaccines and finds a new approach to mitigate common vaccine problems.
It is reported...
Defence’s ACCUMTM variant “A1” converts mesenchymal stromal cells into potent antigen presenting cells
Defence Therapeutics has announced groundbreaking news about the development of a novel anti-cancer cellular vaccine using reprogrammed mesenchymal stromal cells.
Defence Therapeutics Inc., a Canadian...
New mRNA cancer vaccine eliminates tumours
A new mRNA-based cancer vaccine shows potential in eliminating tumours and preventing recurrence in mice.
Cancer vaccines are a controversial topic with plenty of research...
Study finds BCG tuberculosis vaccine offers immune boosting benefits
A study of the BCG tuberculosis vaccine discovers immune boosting benefits in infants over a year after vaccination.
Researchers from the Murdoch Children’s Research Institute (MCRI) and...
New RSV vaccine demonstrates excellent protection
A new RSV vaccine has been shown to provide robust protection against infection in a rodent study at Boston Children's Hospital.
The research was performed...
New COVID vaccine patch fights variants better than needles
A COVID vaccine patch could be more effective than the traditional needle vaccine at fighting COVID variants.
An emerging study by the University of Queensland...
WHO: The integral part that vaccine development plays in tackling AMR
WHO outlines the importance of vaccine development to tackle the ongoing antimicrobial-resistant bacteria pandemic.
In 2021, data revealed the current landscape of AMR. Resistant bacterial...
Covid vaccines prevented 19.8 million deaths in the first year
A modelling study has quantified that Covid vaccines have prevented 19.8 million out of a potential 31.4 million deaths in the first year.
In the...
Versatile Accum technology for various immune-oncology needs
Defence Therapeutics explains how its Accum™ technology can enhance the delivery of tumour and infectious disease-specific therapeutics.
The principal technology developed by Defence Therapeutics (DT)...
Cancer vaccine developed using Oxford-AstraZeneca vaccine technology
Scientists are utilising the same technology used in the creation of the Oxford-AstraZeneca COVID-19 jab to develop a vaccine to treat cancer.
Researchers at the...
$1.5m funding will further research towards TB vaccine
The VALIDATE Network has received a $1.5m funding boost to support its development of a tuberculosis (TB) vaccine.
The Bill & Melinda Gates Foundation have...
Research shows CoronaVac COVID-19 vaccine is safe and effective
An interim analysis of the phase 3 control trial has proven the CoronaVac COVID-19 vaccine to be safe and effective at preventing infection.
The findings,...
Cancer vaccine shows long-lasting anti-tumoural response
A pre-clinical study has demonstrated the anti-tumoural efficacy of the AccuVAC-D001 cancer vaccine.
Developed by biotechnology company Defence Therapeutics Inc., the AccuVAC-D001 cancer vaccine demonstrated...
EU Vaccine Strategy: supporting COVID-19 therapeutics development
The European Commission will be complementing the EU Vaccines Strategy by supporting the development of COVID-19 therapeutics, including the treatment of long-COVID.
As part of...
Cutting-edge UK lab to fast-track COVID-19 variant vaccines
A new state-of-the-art lab in the UK will test the effectiveness of vaccines against new variants of COVID-19.
The new testing lab based at Porton...
COVID-19 vaccines and the route out of the pandemic
The development and rollout of vaccines against COVID-19 form a key step in the journey towards a post-pandemic world.
For the past year, the coronavirus...
COVID-19 vaccine modifications to be fast-tracked to tackle variants
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that modifications to the COVID-19 vaccines will be fast-tracked to help tackle new variants.
COVID-19...
Nanoparticle-delivered COVID-19 vaccine shows strong efficacy
A new nanoparticle-delivered COVID-19 vaccine candidate has shown promising results in preclinical studies.
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health...
Single-dose Janssen COVID-19 vaccine shows 66% effectiveness
New data from the Phase III studies of Janssen’s single-dose COVID-19 vaccine candidate has shown 66% effectiveness in preventing coronavirus in participants.
The UK has...